Topic: Astrazeneca Group
AstraZeneca PLC (NYSE:AZN) could be considered the winner of the swine flu vaccine race, in that the company was the only one to sell a treatment during Q3. It wasn't luck or a head-start that got AstraZeneca's FluMist nasal spray version of ...
AstraZeneca to slash 12 percent of its work force as earnings miss expectationsPharmaceutical company AstraZeneca PLC said Thursday it plans to ax 8,000 more jobs, or 12 percent of its work force, by 2014 to cut costs as it reported disappointing fourth ...
CHICAGO (Reuters) - The U.S. Food and Drug Administration said on Tuesday AstraZeneca's MedImmune unit is voluntarily recalling some of its H1N1 swine flu vaccine because it was not as potent as it should be.Norman Baylor, director of the office of vaccines ...
Astrazeneca will have to solve a shortage on sprayers to be able to deliver the vaccine. So far AstraZeneca only has a license to develop flu vaccines in the U.S., but it has applied for one in Europe, Canada, Hong Kong, among ...
From Around the Web
Video Gallery
-
Penny Stoker - AstraZeneca Pharmaceuticals LP
Penny Stoker, vice presdient, global hr services at AstraZeneca Pharmaceuticals ...2009-04-07 -
AstraZeneca - Tanuj
Tanuj is a physician who combined his health information and ...2011-11-28 -
AstraZeneca - Melissa
Melissa is a Senior Scientist who is part of a ...2011-11-28
